Baird Financial Group’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,003
| Closed | -$24.3K | – | 1710 |
|
|
2023
Q2 | $24.3K | Hold |
3,003
| – | – | ﹤0.01% | 1677 |
|
|
2023
Q1 | $21K | Hold |
3,003
| – | – | ﹤0.01% | 1676 |
|
|
2022
Q4 | $21K | Hold |
3,003
| – | – | ﹤0.01% | 1673 |
|
|
2022
Q3 | $46K | Hold |
3,003
| – | – | ﹤0.01% | 1685 |
|
|
2022
Q2 | $30K | Sell |
3,003
-171,152
| -98% | -$1.71M | ﹤0.01% | 1760 |
|
|
2022
Q1 | $2.51M | Buy |
174,155
+23,348
| +15% | +$336K | 0.01% | 814 |
|
|
2021
Q4 | $7.87M | Buy |
150,807
+40,017
| +36% | +$2.09M | 0.02% | 496 |
|
|
2021
Q3 | $6.46M | Buy |
110,790
+7,195
| +7% | +$419K | 0.02% | 522 |
|
|
2021
Q2 | $8.35M | Buy |
103,595
+5,121
| +5% | +$413K | 0.02% | 464 |
|
|
2021
Q1 | $8.19M | Buy |
98,474
+735
| +0.8% | +$61.2K | 0.02% | 448 |
|
|
2020
Q4 | $7.41M | Buy |
97,739
+2,600
| +3% | +$197K | 0.02% | 447 |
|
|
2020
Q3 | $10.1M | Sell |
95,139
-1,335
| -1% | -$142K | 0.03% | 362 |
|
|
2020
Q2 | $14.6M | Buy |
96,474
+42,380
| +78% | +$6.43M | 0.06% | 291 |
|
|
2020
Q1 | $4.51M | Buy |
54,094
+9,414
| +21% | +$784K | 0.02% | 467 |
|
|
2019
Q4 | $7.55M | Buy |
44,680
+2,691
| +6% | +$455K | 0.03% | 444 |
|
|
2019
Q3 | $7.8M | Buy |
41,989
+2,192
| +6% | +$407K | 0.03% | 398 |
|
|
2019
Q2 | $9.11M | Buy |
39,797
+572
| +1% | +$131K | 0.04% | 379 |
|
|
2019
Q1 | $8.25M | Sell |
39,225
-4,938
| -11% | -$1.04M | 0.05% | 346 |
|
|
2018
Q4 | $5.08M | Buy |
44,163
+27,989
| +173% | +$3.22M | 0.03% | 413 |
|
|
2018
Q3 | $3.55M | Buy |
16,174
+738
| +5% | +$162K | 0.02% | 528 |
|
|
2018
Q2 | $3.44M | Buy |
15,436
+548
| +4% | +$122K | 0.02% | 516 |
|
|
2018
Q1 | $3.4M | Buy |
14,888
+5,026
| +51% | +$1.15M | 0.02% | 502 |
|
|
2017
Q4 | $2.58M | Buy |
+9,862
| New | +$2.58M | 0.02% | 555 |
|
|
2016
Q4 | – | Sell |
-746
| Closed | -$203K | – | 1195 |
|
|
2016
Q3 | $203K | Buy |
+746
| New | +$203K | ﹤0.01% | 1144 |
|